Zobrazeno 1 - 8
of 8
pro vyhledávání: '"S R, Magnuson"'
Autor:
Terry J. Opgenorth, Jinshyun R. Wu-Wong, W. J. Chiou, S. Sundy, S R Magnuson, Douglas B. Dixon
Publikováno v:
Endothelium. 5:179-189
The human type-B endothelin receptor (h-ETB) was cloned from human lung poly A+RNA and stably expressed in CHO cells. Endothelin (ET) receptor binding and stimulation of PI hydrolysis demonstrated that the cloned h-ETB receptor is functional and link
Publikováno v:
The pharmacogenomics journal. 3(1)
The present study successfully utilizes a new ADME Rat Expression Bioarray, containing 1040 metabolism- and toxicology-linked genes, to monitor gene expression from the livers of rats treated with carbon tetrachloride (CCl(4)). Histopathological anal
Publikováno v:
Receptorssignal transduction. 7(3)
Endothelins (ETs) are 21-amino acid peptides that bind to membrane receptors to initiate pathophysiological effects. This report characterizes ET receptors in benign prostatic hyperplasia-1 (BPH-1) cells, a prostate cell line isolated from a specimen
Autor:
J B, Nelson, W H, Lee, S H, Nguyen, D F, Jarrard, J D, Brooks, S R, Magnuson, T J, Opgenorth, W G, Nelson, G S, Bova
Publikováno v:
Cancer research. 57(1)
Production of the potent vasoconstrictor endothelin-1 (ET-1) by human prostate cancer cells accompanies prostate cancer progression in vivo. The predominant endothelin receptor expressed by normal prostate epithelium, ETB, is not expressed by any of
Autor:
J B, Nelson, K, Chan-Tack, S P, Hedican, S R, Magnuson, T J, Opgenorth, G S, Bova, J W, Simons
Publikováno v:
Cancer research. 56(4)
The potent vasoconstrictor endothelin-1 (ET-1) is at its highest concentration in the normal human ejaculate and is associated with the progression of metastatic prostate cancer. ET-1 protein expression is detected in situ in 14 of 14 primary cancers
Autor:
T J, Opgenorth, A L, Adler, S V, Calzadilla, W J, Chiou, B D, Dayton, D B, Dixon, L J, Gehrke, L, Hernandez, S R, Magnuson, K C, Marsh, E I, Novosad, T W, Von Geldern, J L, Wessale, M, Winn, J R, Wu-Wong
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 276(2)
Endothelins (ET) are potent vasoactive peptides implicated in the pathogenesis of a number of vascular diseases. The effects of ET on mammalian organs and cells are initiated by binding to ETA or ETB receptors. In this report, we document the pharmac
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 274(1)
Endothelin (ET) receptor in human astrocytoma U373MG cells was characterized. ET-1, ET-3, sarafotoxin S6C, IRL1620, BQ788, Ro46-2005 and PD142893 inhibited specific [125I]ET-1 binding with Ki values of 0.03 0.06, 0.74, 5.01, 4.45, 2275 and 157 nM, re
Publikováno v:
Molecular pharmacology. 44(2)
Recently the identification of endothelin (ET) receptors and ET in the pituitary gland has induced much interest in studying the potential role of ET in neuroendocrine regulation. MMQ, isolated from rat pituitary, is a prolactin-secreting cell line.